PMP22 and Charcot-Marie-Tooth disease: Our study has shown that, after exclusion of the common PMP22 duplication/deletion, NGS panels can achieve a molecular diagnosis in one third of CMT cases tested in a specialized clinical diagnostic setting, which includes a dedicated post genetic analysis multidisciplinary case discussion.